Gene165
AEBP1: AE binding protein 1
Cite this record
ConductScience Library. AEBP1: AE binding protein 1. Genes, record 165. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/165
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8IUX7 | Adipocyte enhancer-binding protein 1 | 1,158 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents122
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260201011 A1 | 2026-07-16 | 14725 | Q8IUX7 | Espacenet |
| US 20260201011 A1 | 2026-07-16 | 574 | Q8IUX7 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 416 | Q8IUX7 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 5426 | Q8IUX7 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 14725 | Q8IUX7 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 574 | Q8IUX7 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 14725 | Q8IUX7 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 574 | Q8IUX7 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 597 | Q8IUX7 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 416 | Q8IUX7 | Espacenet |
NIH grants449
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AEBP1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 2 | 2025 |
| P30ES013508 | Center of Excellence in Environmental Toxicology | 2 | 2025 |
| R01EY021797 | Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency | 2 | 2025 |
| R01HL092577 | IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL | 2 | 2025 |
| R01HL157635 | Using Electrocardiogram Genetics to Inform Arrhythmia Risk | 2 | 2025 |
| U54GM104942 | West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health | 2 | 2025 |
| I01BX003056 | Sirtuins in Lung Aging and Fibrosis | 1 | 2025 |
| I01BX003824 | Advanced conformational changes in NOTCH3 and cerebrovascular disease severity | 1 | 2025 |
| IK6RX003075 | RR&D Research Career Scientist Award Application | 1 | 2025 |
Source NIH's project files
Papers714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell Proteomics Uncovers Cell-Specific Proteins in Vascular Health and Marfan Syndrome Disease-Brief Report. | Arterioscler Thromb Vasc Biol | 2026 | 42592649 | PubTator, text mining | PubMed |
| Integrating Large-Scale Bulk and Single-Cell RNA Sequencing with Machine Learning: Unveiling the Cytokine Landscape of Glioblastoma and Constructing a Prognostic Feature Model. | Curr Cancer Drug Targets | 2026 | 42576525 | PubTator, text mining | PubMed |
| Magnetically guided apoptotic mesenchymal stem cell-derived nanovesicles for the modulation of pathological remodeling in cardiac injury. | Acta Biomater | 2026 | 42570782 | PubTator, text mining | PubMed |
| The m6A reader IGF2BP2 promotes hepatic fibrosis by stabilizing AEBP1 mRNA and regulating GRB2-mediated hepatic stellate cell activation. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42508775 | PubTator, text mining | PubMed |
| Adipocyte Enhancer Binding Protein 1 (AEBP1) Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure. | Res Sq | 2026 | 42245802 | PubTator, text mining | PubMed |
| Gastrointestinal involvement in Ehlers-Danlos syndrome classical-like type 2 associated with a novel AEBP1 splice-site variant. | J Hum Genet | 2026 | 42191857 | PubTator, text mining | PubMed |
| Key role of transcription factors network in proliferative vitreoretinal diseases development. | Cell Biosci | 2026 | 42104523 | PubTator, text mining | PubMed |
| Bioinformatics analysis implicates ferroptosis and key hub genes in the pathogenesis of endometriosis. | J Obstet Gynaecol | 2026 | 42060917 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics. | Gigascience | 2026 | 41880523 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/165
GET https://conductscience.org/api/genes/v1/165/patents?page=2